
Only 1 in 20 cancer patients joins a clinical trial, partly because finding one means decoding clinical language across sites that disagree. Mayo Clinic sponsored our six-person team to design a patient-facing alternative. I designed the end-to-end screen flows that connect patient and caregiver journeys, and shaped how the AI explains every match.
Interviews
Concepts Merged
reworked after lo-fi testing



COMPETITIVE ANALYSIS
Three sites, three answers
None explained why a trial actually fits.

AFFINITY MAPPING
Confusion, not lack of interest
Patients stalled on jargon and unclear next steps.

TARGETED INTERVIEWS
Clarity was the gap
Physicians, speaking for patients,
saw the same drop-off.
Let patients choose
Records are more
Leave the final call
Search is scattered across sites that disagree with each other.
Trust in AI is conditional. Patients need the why.
Search is scattered across sites that disagree with each other.
Caregivers do unpaid case management with no tool built for it.
The hardest part isn’t medical. It’s emotional.
We merged three concepts into one direction, then I connected every patient and caregiver screen.

Think-aloud reviews and semi-structured interviews with physicians and faculty, before the final design.

The full patient journey in one prototype, built to test with physicians and faculty.
We ran think-aloud reviews and semi-structured interviews with physicians and faculty, then reworked five areas before the final design.

Low-Fidelity onboarding screen flows asked for a full medical history upfront. Physicians found it too long and daunting for someone who was just diagnosed. We cut it to the essentials and moved the deeper questions to TrialGuide, later in the journey.
Tradeoff: We chose a likelihood breakdown over a simple yes or no, because patients needed to see why they might qualify, not just whether.
Think-aloud reviews and semi-structured interviews with physicians and faculty, before the final design.
Our high-fidelity onboarding asked for a full medical history upfront. Physicians found it too long and daunting for someone just diagnosed, so we cut it to the essentials and moved deeper questions to the TrialGuide chatbot.
For someone facing cancer, one confusing word can stop them. Owning the flows taught me that most
of the complexity sits between screens.
If I did it again with AI
Pressure-test plain-language eligibility with an LLM before designing.
Map every likelihood state early.
Build in a “Did this make sense?” check from day one.
- Test with real patients
- Clinician dashboards
- Accessibility audit
